vs

Side-by-side financial comparison of Lakeside Holding Ltd (LSH) and SR Bancorp, Inc. (SRBK). Click either name above to swap in a different company.

SR Bancorp, Inc. is the larger business by last-quarter revenue ($8.4M vs $7.0M, roughly 1.2× Lakeside Holding Ltd). SR Bancorp, Inc. runs the higher net margin — 10.0% vs -22.6%, a 32.5% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs 6.4%).

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

SR Bancorp Inc. is a regional bank holding company based in the United States. It offers a full range of consumer and commercial banking services including deposit products, personal loans, mortgage lending, small business financing, and commercial credit solutions, primarily serving local communities and small to mid-sized enterprises in its operating areas.

LSH vs SRBK — Head-to-Head

Bigger by revenue
SRBK
SRBK
1.2× larger
SRBK
$8.4M
$7.0M
LSH
Growing faster (revenue YoY)
LSH
LSH
+88.6% gap
LSH
95.0%
6.4%
SRBK
Higher net margin
SRBK
SRBK
32.5% more per $
SRBK
10.0%
-22.6%
LSH

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
LSH
LSH
SRBK
SRBK
Revenue
$7.0M
$8.4M
Net Profit
$-1.6M
$834.0K
Gross Margin
27.2%
Operating Margin
-21.3%
13.0%
Net Margin
-22.6%
10.0%
Revenue YoY
95.0%
6.4%
Net Profit YoY
18.7%
-18.3%
EPS (diluted)
$-0.08
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LSH
LSH
SRBK
SRBK
Q4 25
$7.0M
$8.4M
Q3 25
$6.1M
$8.2M
Q2 25
$6.3M
$7.6M
Q1 25
$3.8M
$7.7M
Q4 24
$3.6M
$7.9M
Q3 24
$4.1M
$8.4M
Q2 24
$7.9M
Q1 24
$8.8M
Net Profit
LSH
LSH
SRBK
SRBK
Q4 25
$-1.6M
$834.0K
Q3 25
$-1.4M
$693.0K
Q2 25
$-893.1K
$2.2M
Q1 25
$-1.1M
$537.0K
Q4 24
$-1.9M
$1.0M
Q3 24
$-1.3M
$1.4M
Q2 24
$-3.0M
Q1 24
$1.1M
Gross Margin
LSH
LSH
SRBK
SRBK
Q4 25
27.2%
Q3 25
18.2%
Q2 25
26.7%
Q1 25
18.8%
Q4 24
-1.2%
Q3 24
12.8%
Q2 24
Q1 24
Operating Margin
LSH
LSH
SRBK
SRBK
Q4 25
-21.3%
13.0%
Q3 25
-20.8%
11.0%
Q2 25
-8.9%
32.1%
Q1 25
-28.2%
8.1%
Q4 24
-55.6%
17.1%
Q3 24
-32.5%
20.6%
Q2 24
-34.0%
Q1 24
15.4%
Net Margin
LSH
LSH
SRBK
SRBK
Q4 25
-22.6%
10.0%
Q3 25
-22.2%
8.5%
Q2 25
-14.2%
29.2%
Q1 25
-28.2%
7.0%
Q4 24
-54.1%
13.0%
Q3 24
-32.7%
16.3%
Q2 24
-38.2%
Q1 24
12.1%
EPS (diluted)
LSH
LSH
SRBK
SRBK
Q4 25
$-0.08
$0.11
Q3 25
$-0.09
$0.09
Q2 25
$-0.11
$0.27
Q1 25
$-0.14
$0.06
Q4 24
$-0.26
$0.12
Q3 24
$-0.18
$0.16
Q2 24
$8.14
Q1 24
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LSH
LSH
SRBK
SRBK
Cash + ST InvestmentsLiquidity on hand
$1.6M
$81.8M
Total DebtLower is stronger
$2.4M
Stockholders' EquityBook value
$12.2M
$188.5M
Total Assets
$24.3M
$1.1B
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LSH
LSH
SRBK
SRBK
Q4 25
$1.6M
$81.8M
Q3 25
$4.5M
$58.3M
Q2 25
$5.0M
$57.8M
Q1 25
$1.5M
$62.2M
Q4 24
$1.1M
$53.4M
Q3 24
$2.7M
$47.3M
Q2 24
$45.9M
Q1 24
$72.5M
Total Debt
LSH
LSH
SRBK
SRBK
Q4 25
$2.4M
Q3 25
$2.4M
Q2 25
$1.4M
Q1 25
$774.2K
Q4 24
$784.8K
Q3 24
$589.9K
Q2 24
Q1 24
Stockholders' Equity
LSH
LSH
SRBK
SRBK
Q4 25
$12.2M
$188.5M
Q3 25
$7.0M
$191.9M
Q2 25
$2.8M
$193.8M
Q1 25
$749.8K
$195.1M
Q4 24
$1.6M
$198.1M
Q3 24
$3.6M
$200.5M
Q2 24
$199.5M
Q1 24
$199.3M
Total Assets
LSH
LSH
SRBK
SRBK
Q4 25
$24.3M
$1.1B
Q3 25
$18.6M
$1.1B
Q2 25
$14.4M
$1.1B
Q1 25
$9.9M
$1.1B
Q4 24
$9.8M
$1.1B
Q3 24
$10.8M
$1.1B
Q2 24
$1.0B
Q1 24
$1.1B
Debt / Equity
LSH
LSH
SRBK
SRBK
Q4 25
0.20×
Q3 25
0.35×
Q2 25
0.48×
Q1 25
1.03×
Q4 24
0.48×
Q3 24
0.16×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LSH
LSH
SRBK
SRBK
Operating Cash FlowLast quarter
$-453.5K
$3.6M
Free Cash FlowOCF − Capex
$3.1M
FCF MarginFCF / Revenue
37.0%
Capex IntensityCapex / Revenue
5.9%
Cash ConversionOCF / Net Profit
4.31×
TTM Free Cash FlowTrailing 4 quarters
$11.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LSH
LSH
SRBK
SRBK
Q4 25
$-453.5K
$3.6M
Q3 25
$-4.0M
$1.2M
Q2 25
$-483.7K
$4.7M
Q1 25
$-238.3K
$2.6M
Q4 24
$-530.2K
$-1.4M
Q3 24
$-1.4M
$1.8M
Q2 24
$-1.7M
Q1 24
$-3.9M
Free Cash Flow
LSH
LSH
SRBK
SRBK
Q4 25
$3.1M
Q3 25
$1.1M
Q2 25
$-497.4K
$4.2M
Q1 25
$2.5M
Q4 24
$-560.5K
$-1.5M
Q3 24
$-1.4M
$1.7M
Q2 24
$-2.8M
Q1 24
$-4.0M
FCF Margin
LSH
LSH
SRBK
SRBK
Q4 25
37.0%
Q3 25
14.0%
Q2 25
-7.9%
55.9%
Q1 25
32.3%
Q4 24
-15.6%
-19.5%
Q3 24
-34.5%
20.3%
Q2 24
-35.8%
Q1 24
-45.2%
Capex Intensity
LSH
LSH
SRBK
SRBK
Q4 25
5.9%
Q3 25
0.9%
Q2 25
0.2%
5.7%
Q1 25
0.0%
1.0%
Q4 24
0.8%
1.3%
Q3 24
0.1%
1.0%
Q2 24
13.9%
Q1 24
0.5%
Cash Conversion
LSH
LSH
SRBK
SRBK
Q4 25
4.31×
Q3 25
1.76×
Q2 25
2.11×
Q1 25
4.79×
Q4 24
-1.40×
Q3 24
1.31×
Q2 24
Q1 24
-3.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

SRBK
SRBK

Segment breakdown not available.

Related Comparisons